Microdermis iodine-based antiseptic adopted by US Army in fight against Ebola

By Kasia Patel
Published: Friday, 05 December 2014

The company’s iodine-based product, Provodine, together with its unique topical drug delivery system, has been tested by the US Army and shown to kill 99% of the virus. Adoption by the US Army lends backing to the product, and Mircrodermis has ramped up production, anticipating an increase in demand.

Privately-owned life sciences company Microdermis Corp. has launched a new iodine-based antiseptic product, which will be deployed by the US Army to help fight the spread of Ebola in West Africa.

The antiseptic skin product, Provodine, is applied as a final molecular barrier for healthcare workers and emergency responders using...

This is a preview of the full article

Our market news and price data is reserved for registered users only.

Current customer? Login now

All of our industrial minerals price data and news is now available only through our new platform. Learn more about the intelligence we offer by visiting our Fastmarkets flagship website. If you are familiar with our reliable and trusted intelligence, fill out a request a quote form today to hear from our friendly sales staff who will create a custom license for you.


           



Interested in lithium prices? We now offer lithium prices and coverage free for reference. Click here to read all about it.

Interested in the wider electrification market?
Join our growing community of participants who want to learn more about electrification and how this market is developing.